Never Run Out Of Buyers To Sell To.

At Aniling, we are committed to bringing advances in the Genomics arena to everyday health care and disease prevention. We aim to accelerate epigenomics to help make precision medicine a reality. Aniling has patented the GEUS technology (Genomic and Epigenomic Unified Sequencing), which allows for the rst time simultaneous and high-reliability analysis of genome and epigenome, and provides end-to-end solutions for the right treatment decisions in oncology. Our company is a spin-off of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC), currently integrated in the Germans…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.